Altered Lipid Metabolism in Autosomal Dominant Polycystic Kidney Disease Patients Treated With Tolvaptan

被引：0
|
作者：
Bargagli, Matteo [1 ,2 ]
Anderegg, Manuel [1 ]
Ferraro, Pietro Manuel [2 ,3 ]
Fuster, Daniel G. [1 ]
机构：
[1] Univ Bern, Bern Univ Hosp, Dept Hypertens & Nephrol, Inselspital, Bern, Switzerland
[2] Univ Cattolica Sacro Cuore, Dipartimento Univ Med & Chirurg Traslaz, Rome, Italy
[3] Fdn Policlin Univ A Gemelli IRCCS, UOC Nefrol, Rome, Italy
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
TH-PO409
引用
收藏
页码：160 / 161
页数：2
相关论文
共 50 条
  • [1] Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
    Torres, Vicente E.
    Chapman, Arlene B.
    Devuyst, Olivier
    Gansevoort, Ron T.
    Grantham, Jared J.
    Higashihara, Eiji
    Perrone, Ronald D.
    Krasa, Holly B.
    Ouyang, John
    Czerwiec, Frank S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25): : 2407 - 2418
  • [2] Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients Treated With Tolvaptan
    Anderegg, Manuel A.
    Dhayat, Nasser A.
    Sommer, Grit
    Semmo, Mariam
    Huynh-Do, Uyen
    Vogt, Bruno
    Fuster, Daniel G.
    KIDNEY MEDICINE, 2020, 2 (02) : 162 - 171
  • [3] Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
    Spital, Aaron
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (13): : 1257 - 1257
  • [4] Tolvaptan and Autosomal Dominant Polycystic Kidney Disease
    Ingelfinger, Julie R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1988 - 1989
  • [5] Tolvaptan in Autosomal Dominant Polycystic Kidney Disease Reply
    Torres, Vicente E.
    Gansevoort, Ron T.
    Czerwiec, Frank S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (13): : 1259 - 1259
  • [6] Review of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease
    Baur, Brian P.
    Meaney, Calvin J.
    PHARMACOTHERAPY, 2014, 34 (06): : 605 - 616
  • [7] The effect of tolvaptan on kidney function in patients with autosomal dominant polycystic kidney disease
    Kawada, Tomoyuki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2016, 20 (01) : 147 - 148
  • [8] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Blair, Hannah A.
    DRUGS, 2019, 79 (03) : 303 - 313
  • [9] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Hannah A. Blair
    Gillian M. Keating
    Drugs, 2015, 75 : 1797 - 1806
  • [10] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Hannah A. Blair
    Drugs, 2019, 79 : 303 - 313
12345